KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sysco (SYY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Sysco (SYY) over the last 17 years, with Q4 2025 value amounting to $1.2 billion.

  • Sysco's Cash & Equivalents rose 5409.84% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 5409.84%. This contributed to the annual value of $1.1 billion for FY2025, which is 5387.93% up from last year.
  • As of Q4 2025, Sysco's Cash & Equivalents stood at $1.2 billion, which was up 5409.84% from $844.0 million recorded in Q3 2025.
  • Over the past 5 years, Sysco's Cash & Equivalents peaked at $4.9 billion during Q1 2021, and registered a low of $437.7 million during Q4 2022.
  • Its 5-year average for Cash & Equivalents is $1.2 billion, with a median of $855.5 million in 2022.
  • In the last 5 years, Sysco's Cash & Equivalents plummeted by 8210.4% in 2022 and then soared by 15535.12% in 2025.
  • Over the past 5 years, Sysco's Cash & Equivalents (Quarter) stood at $2.1 billion in 2021, then plummeted by 75.8% to $500.3 million in 2022, then surged by 92.27% to $962.0 million in 2023, then dropped by 17.57% to $793.0 million in 2024, then surged by 54.1% to $1.2 billion in 2025.
  • Its Cash & Equivalents stands at $1.2 billion for Q4 2025, versus $844.0 million for Q3 2025 and $1.1 billion for Q2 2025.